908 Devices

908 Devices LT Debt/Equity

The Long-Term Debt to Equity Ratio of 908 Devices (MASS) as of Oct 15, 2026 is 0.08. In the previous year, Long-Term Debt to Equity Ratio was 0.07 — a change of 12.59% (higher).

LT Debt/Equity

0.08

YoY

12.59%

Last updated:

Long-Term Debt to Equity Ratio of 908 Devices is 2022 0.08 . Long-Term Debt to Equity Ratio of 908 Devices was 2021 0.07 . It decreases by 12.59% higher compared to the previous year.

The 908 Devices LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2018
-0.19 USD
Jan 1, 2019
-0.23 USD
Jan 1, 2020
0.10 USD
Jan 1, 2021
0.07 USD
Jan 1, 2022
0.08 USD
The 908 Devices LT Debt/Equity history
YEARLT Debt/EquityYoY
0.08+12.59%
0.07-32.19%
0.10-144.09%
-0.23+21.57%
-0.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

908 Devices Stock analysis

What does 908 Devices do? The company 908 Devices was founded in Boston in 2012 and specializes in the development and manufacturing of innovative analysis devices. The idea behind the company was to develop portable devices that would allow users to perform quick and accurate analyses on-site. 908 Devices' business model is based on the development and marketing of devices for the chemistry, pharmaceutical, and biotech industries, as well as for applications in the security and defense sectors. The company has several product lines tailored to different applications, including portable devices for mobile use. One of the most important branches of 908 Devices is mass spectrometry, a method used in many areas of analytics, such as forensics, environmental analysis, and food control. 908 Devices has developed a technology that allows for compact and portable mass spectrometry, which was not previously possible. Another important area of 908 Devices is chromatography, a method used for separating substances. Here too, the company has developed a technology that allows for the offering of chromatography in portable devices. 908 Devices also offers devices for molecular spectroscopy, including Raman spectroscopy, which allows for the identification and characterization of molecules. Raman spectroscopy is used in many applications, such as pharmaceutical research and material analysis. Among the products offered by 908 Devices are the M908 and MX908 devices, specifically designed for use in the security and defense industry. These devices allow for the real-time detection of a variety of hazardous substances, such as explosives, drugs, or dangerous chemicals. Another product of 908 Devices is the ZipChip device, used in biotech research. The ZipChip allows for the analysis of proteins in a very short time, which is of great importance in pharmaceutical research. The company has received several awards in recent years, including the R&D 100 Award and the Innovation Award of Analytica, one of the world's most important trade fairs for analytics and laboratory technology. Overall, 908 Devices has achieved an impressive success story and aims to revolutionize the way analyses are conducted. With its innovative products and technologies, the company has found a niche in the market and has experienced strong growth. 908 Devices is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 908 Devices stock

Long-Term Debt to Equity Ratio of 908 Devices is 0.08 in 2022.

Long-Term Debt to Equity Ratio of 908 Devices changed from 0.07 to 0.08, representing a 12.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio 908 Devices since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's 908 Devices with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — 908 Devices

All Key Metrics — 908 Devices